What it is
Cervidil is a small tampon-like insert containing dinoprostone (prostaglandin E2). It sits against the cervix and slowly releases medication for up to about 12 hours. Prepidil is the gel form. Because it has a string, it can be removed if contractions become too strong or the baby doesn't tolerate it — a key advantage over misoprostol.
Evidence review links
Each link opens the full review on the publisher's site in a new tab.
Possible benefits
- Removable if contractions become too strong or non-reassuring changes appearReview sources ↓
- FDA-approved specifically for cervical ripeningReview sources ↓
- Often effective without needing PitocinReview sources ↓
Possible risks
- Higher cost than misoprostolReview sources ↓
- Still carries a risk of tachysystoleReview sources ↓
- Generally avoided with a prior uterine scarReview sources ↓
Alternatives
- Misoprostol (Cytotec) — cheaper, non-removable prostaglandinReview sources ↓
- Foley/Cook balloon — mechanical, no medicationReview sources ↓
- Pitocin if the cervix is already favorableReview sources ↓
Current evidence
ACOG's induction bulletin lists dinoprostone as an accepted first-line ripening agent. Comparative trials show similar effectiveness to misoprostol with a somewhat lower rate of tachysystole and the advantage of being removable. Evidence Based Birth's due-date induction and cervical-ripening resources can help you compare medication vs. mechanical methods. See: https://evidencebasedbirth.com/evidence-on-inducing-labor-for-going-past-your-due-date/
Where the evidence is clear · where people may choose differently
For most topics, guidelines from ACOG, WHO, and other major bodies broadly agree on the core safety points (when to act in an emergency, informed-consent standards, monitoring baselines). Where reasonable people — and even guidelines — differ tends to be around thresholds (when to start or stop something), preferences (comfort, environment, support), and values (how you weigh small risks against benefits). Use the questions below to explore those pieces with your care team.
Educational only. Your care team can help you weigh what applies to your specific situation.
Questions to ask your care team
- ?How long will you leave the insert in, and what triggers removing it?
- ?How soon after removal can we start Pitocin if needed?
- ?How does Cervidil compare with misoprostol or a Foley for my situation?
Universal questions (works for any decision)
A short BRAIN-style set you can bring to any conversation about interventions, monitoring, or care decisions.
- ?Why are you recommending this now — is it urgent, routine, or optional?
- ?What happens if we wait an hour (or longer) before deciding?
- ?What signs would tell us this is working — or that we need to change course?
- ?What are the alternatives, including doing nothing?
- ?What would you recommend if this were your family?
- ?What would change your recommendation?
Sources & provenance
Tap a source to open the original guideline or review in a new tab.
- ACOG Practice Bulletin 107: Induction of Labor — ACOG
- Evidence on: Inducing at 41 Weeks or Later — Evidence Based Birth
Written in plain language from general guidance published by the listed organizations. No verbatim excerpts; editors should re-verify wording and citations against current source versions before publish.
Last reviewed: 2026-07-02
Further reading — canonical references
Read the source material directly. Each link opens the publisher's own current guidance in a new tab — cross-check what we summarize against what they say.
Tier 1 · Clinical guidelines
Tier 2 · Systematic reviews
Educational only. Guidelines evolve — the linked publisher pages will reflect newer guidance than any static snapshot.
Version history — v1.0.0
v1.0.0 · 2026-07-02 · LlaMamma editors
Initial Cervidil/dinoprostone topic added with ACOG and Evidence Based Birth induction links.
Sources: ACOG Practice Bulletin 107; Evidence Based Birth due-date induction review
New guidance from ACOG, WHO, Evidence Based Birth, or other listed sources is recorded here and can be updated remotely without a new app release.